AAAAAA

   
Results: 1-18 |
Results: 18
A PHASE-II STUDY OF NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN, EPIRUBICIN AND VP-16 FOR STAGE-III UNRESECTABLE NONSMALL CELL LUNG-CANCER
Authors: IACOBELLI S IRTELLI L SACCO R MARTINO M MASCITELLI E BASILICO L SCOGNAMIGLIO M NATOLI C FUSCO O TINARI N BELTRAMI V
Citation: S. Iacobelli et al., A PHASE-II STUDY OF NEOADJUVANT CHEMOTHERAPY WITH CISPLATIN, EPIRUBICIN AND VP-16 FOR STAGE-III UNRESECTABLE NONSMALL CELL LUNG-CANCER, Anticancer research, 18(3B), 1998, pp. 2081-2084
90K (MAC-2 BP) PREDICTS CD4 DECLINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH CD4 COUNTS ABOVE 200 X 10(6) CELLS L/
Authors: TINARI N NATOLI C DOSTILIO N GHINELLI F SIGHINOLFI L ORTONA L TAMBURRINI E PIAZZA M CHIRIANNI A GUERRA L DIGREGORIO P IACOBELLI S
Citation: N. Tinari et al., 90K (MAC-2 BP) PREDICTS CD4 DECLINE IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH CD4 COUNTS ABOVE 200 X 10(6) CELLS L/, Archives of pathology and laboratory medicine, 122(2), 1998, pp. 178-181
IDENTIFICATION OF THE TUMOR-ANTIGEN 90K DOMAINS RECOGNIZED BY MONOCLONAL-ANTIBODIES SP2 AND L3 AND PREPARATION AND CHARACTERIZATION OF NOVEL ANTI-90K MONOCLONAL-ANTIBODIES
Authors: TINARI N DEGIDIO M IACOBELLI S BOWEN M STARLING G SEACHORD C DARVEAU R ARUFFO A
Citation: N. Tinari et al., IDENTIFICATION OF THE TUMOR-ANTIGEN 90K DOMAINS RECOGNIZED BY MONOCLONAL-ANTIBODIES SP2 AND L3 AND PREPARATION AND CHARACTERIZATION OF NOVEL ANTI-90K MONOCLONAL-ANTIBODIES, Biochemical and biophysical research communications, 232(2), 1997, pp. 367-372
A FLOW CYTOMETRIC STUDY OF EARLY GASTRIC-CANCER - THE DETECTION OF HIGH PROLIFERATIVE ACTIVITY ADDS IMPORTANT INFORMATION TO THE PROGNOSIS
Authors: RANALDI R SANTINELLI A FABRIS G MANNELLO B NATOLI C TINARI N BEARZI I
Citation: R. Ranaldi et al., A FLOW CYTOMETRIC STUDY OF EARLY GASTRIC-CANCER - THE DETECTION OF HIGH PROLIFERATIVE ACTIVITY ADDS IMPORTANT INFORMATION TO THE PROGNOSIS, Pathology research and practice, 192(12), 1996, pp. 1202-1205
VIREMIA, HCV GENOTYPE AND 90K MAC-2BP LEVELS AS PREDICTORS OF RESPONSE TO A-IFN THERAPY/
Authors: ARTINI M NATOLI C COSTANZO A GRASSADONIA A PORCARI P DEGIDIO M TINARI N BALSANO C PAROLI M IACOBELLI S LEVRERO M
Citation: M. Artini et al., VIREMIA, HCV GENOTYPE AND 90K MAC-2BP LEVELS AS PREDICTORS OF RESPONSE TO A-IFN THERAPY/, Hepatology, 24(4), 1996, pp. 143-143
ELEVATED SERUM LEVELS OF 90K MAC-2 BP PREDICT UNRESPONSIVENESS TO ALPHA-INTERFERON THERAPY IN CHRONIC HCV HEPATITIS PATIENTS/
Authors: ARTINI M NATOLI C TINARI N COSTANZO A MARINELLI R BALSANO C PORCARI P ANGELUCCI D DEGIDIO M LEVRERO M IACOBELLI S
Citation: M. Artini et al., ELEVATED SERUM LEVELS OF 90K MAC-2 BP PREDICT UNRESPONSIVENESS TO ALPHA-INTERFERON THERAPY IN CHRONIC HCV HEPATITIS PATIENTS/, Journal of hepatology, 25(2), 1996, pp. 212-217
THE 90K TUMOR-ASSOCIATED ANTIGEN AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: IACOBELLI S ULLRICH A TINARI N ORTONA L TAMBURRINI E DEGIDIO M GHINELLI F SIGHINOLFI L PIAZZA M CHIRIANNI A GUERRA L NATOLI C
Citation: S. Iacobelli et al., THE 90K TUMOR-ASSOCIATED ANTIGEN AND CLINICAL PROGRESSION IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Journal of acquired immune deficiency syndromes and human retrovirology, 10(4), 1995, pp. 450-456
A PHASE-I STUDY OF RECOMBINANT INTERFERON-ALPHA ADMINISTERED AS A 7-DAY CONTINUOUS VENOUS INFUSION AT CIRCADIAN-RHYTHM MODULATED RATE IN PATIENTS WITH CANCER
Authors: IACOBELLI S GARUFI C IRTELLI L MARTINO MT SANTOBUONO F VICARIO G TINARI N FIORENTINO B INNOCENTI P NATOLI C
Citation: S. Iacobelli et al., A PHASE-I STUDY OF RECOMBINANT INTERFERON-ALPHA ADMINISTERED AS A 7-DAY CONTINUOUS VENOUS INFUSION AT CIRCADIAN-RHYTHM MODULATED RATE IN PATIENTS WITH CANCER, American journal of clinical oncology, 18(1), 1995, pp. 27-31
HCV GENOTYPE AND SERUM 90K LEVELS - HOST AND VIRUS-RELATED FACTORS PREDICT RESPONSE TO A-IFN THERAPY
Authors: ARTINI M NATOLI C COSTANZO A TINARI N MARINELLI R ANGELUCCI D DEGIDIO M BALSANO C NATOLI G IACOBELLI S LEVRERO M
Citation: M. Artini et al., HCV GENOTYPE AND SERUM 90K LEVELS - HOST AND VIRUS-RELATED FACTORS PREDICT RESPONSE TO A-IFN THERAPY, Hepatology, 22(4), 1995, pp. 276-276
PANCREATIC-JUICE 90K AND SERUM CA-19-9 COMBINED DETERMINATION CAN DISCRIMINATE BETWEEN PANCREATIC-CANCER AND CHRONIC-PANCREATITIS
Authors: GENTILONI N CARADONNA P COSTAMAGNA G DOSTILIO N PERRI V MUTIGNANI M FEBBRARO S TINARI N IACOBELLI S NATOLI C
Citation: N. Gentiloni et al., PANCREATIC-JUICE 90K AND SERUM CA-19-9 COMBINED DETERMINATION CAN DISCRIMINATE BETWEEN PANCREATIC-CANCER AND CHRONIC-PANCREATITIS, The American journal of gastroenterology, 90(7), 1995, pp. 1069-1072
90K IS A SERUM MARKER OF POOR-PROGNOSIS IN NON-HODGKINS-LYMPHOMA PATIENTS
Authors: REA A PALMIERI G TINARI N NATOLI C TAGLIAFERRI P MORABITO A GRASSADONIA A BIANCO AR IACOBELLI S
Citation: A. Rea et al., 90K IS A SERUM MARKER OF POOR-PROGNOSIS IN NON-HODGKINS-LYMPHOMA PATIENTS, Oncology Reports, 1(4), 1994, pp. 723-725
ELEVATED SERUM LEVELS OF A 90,000-DALTONS TUMOR-ASSOCIATED ANTIGEN INCANCER AND IN INFECTION BY HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)
Authors: NATOLI C ORTONA L TAMBURRINI E TINARI N DISTEFANO P DEGIDIO M GHINELLI F SIGHINOLFI L DOSTILIO N PIAZZA M GRASSADONIA A IACOBELLI D IACOBELLI S
Citation: C. Natoli et al., ELEVATED SERUM LEVELS OF A 90,000-DALTONS TUMOR-ASSOCIATED ANTIGEN INCANCER AND IN INFECTION BY HUMAN-IMMUNODEFICIENCY-VIRUS (HIV), Anticancer research, 14(3B), 1994, pp. 1457-1460
PROGNOSTIC VALUE OF A NOVEL CIRCULATING SERUM 90K ANTIGEN IN BREAST-CANCER
Authors: IACOBELLI S SISMONDI P GIAI M DEGIDIO M TINARI N AMATETTI C DISTEFANO P NATOLI C
Citation: S. Iacobelli et al., PROGNOSTIC VALUE OF A NOVEL CIRCULATING SERUM 90K ANTIGEN IN BREAST-CANCER, British Journal of Cancer, 69(1), 1994, pp. 172-176
MORE ON BARNES -GALLERY-OF-ART( RESPONSE TO HIGONNET,ANNE ARTICLE ON THE NATIONAL)
Authors: TINARI N
Citation: N. Tinari, MORE ON BARNES -GALLERY-OF-ART( RESPONSE TO HIGONNET,ANNE ARTICLE ON THE NATIONAL), ART AM, 82(6), 1994, pp. 27-27
EXPRESSION OF HER-2 NEU ONCOPROTEIN, DNA-PLOIDY AND S-PHASE FRACTION IN ADVANCED OVARIAN-CANCER
Authors: SCAMBIA G PANICI PB FERRANDINA G BATTAGLIA F BAIOCCHI G DISTEFANO P TINARI N CORONETTA F PIANTELLI M NATALI P IACOBELLI S MANCUSO S
Citation: G. Scambia et al., EXPRESSION OF HER-2 NEU ONCOPROTEIN, DNA-PLOIDY AND S-PHASE FRACTION IN ADVANCED OVARIAN-CANCER, International journal of gynecological cancer, 3(5), 1993, pp. 271-278
LACK OF PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICAL DETERMINATION OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN HUMAN PROSTATE-CANCER
Authors: AMATETTI C ANGELUCCI D FIORENTINO B TINARI N DISTEFANO P TENAGLIA R IACOBELLI S NATOLI C
Citation: C. Amatetti et al., LACK OF PROGNOSTIC VALUE OF IMMUNOHISTOCHEMICAL DETERMINATION OF EPIDERMAL GROWTH-FACTOR RECEPTORS IN HUMAN PROSTATE-CANCER, International journal of oncology, 3(5), 1993, pp. 887-889
A 90-KDA PROTEIN SERUM MARKER FOR THE PREDICTION OF PROGRESSION TO AIDS IN A COHORT OF HIV-1+ HOMOSEXUAL MEN
Authors: BRIGGS NC NATOLI C TINARI N DEGIDIO M GOEDERT JJ IACOBELLI S
Citation: Nc. Briggs et al., A 90-KDA PROTEIN SERUM MARKER FOR THE PREDICTION OF PROGRESSION TO AIDS IN A COHORT OF HIV-1+ HOMOSEXUAL MEN, AIDS research and human retroviruses, 9(9), 1993, pp. 811-816
PROGNOSTIC VALUE OF A NOVEL CIRCULATING SERUM 90K ANTIGEN IN HIV-INFECTED HEMOPHILIA PATIENTS
Authors: LONGO G NATOLI C RAFANELLI D TINARI N MORFINI M ROSSIFERRINI P DOSTILIO N IACOBELLI S
Citation: G. Longo et al., PROGNOSTIC VALUE OF A NOVEL CIRCULATING SERUM 90K ANTIGEN IN HIV-INFECTED HEMOPHILIA PATIENTS, British Journal of Haematology, 85(1), 1993, pp. 207-209
Risultati: 1-18 |